← Back to headlines
Jim Cramer Labels Beam Therapeutics a "Speculative Situation"
Financial analyst Jim Cramer characterized Beam Therapeutics as a "speculative situation," indicating a high-risk, high-reward investment.
30 Apr, 19:17 — 30 Apr, 19:17
Sources
Showing 1 of 1 sources
